Ubiquitous Kinesin Heavy Chain Activators are a collection of chemical compounds that enhance the activity of Ubiquitous Kinesin Heavy Chain (KIF5B) through various intracellular mechanisms. ATP, essential for the motor activity of KIF5B, binds to its ATPase domain and upon hydrolysis, supplies the necessary energy for conformational changes that propel the kinesin along microtubules. Microtubule-stabilizing agents such as Paclitaxel further support KIF5B's function by preventing the disassembly of microtubules, thus maintaining the structural tracks for kinesin movement. Additionally, signaling molecules like Insulin and EGF indirectly promote KIF5B activity by activating pathways that lead to the phosphorylation of kinesin light chains or associated proteins, thereby modulating cargo binding and motor function. The use of phosphatase inhibitors Calyculin A and Okadaic Acid results in the hyperphosphorylation of cellular proteins, which couldenhance KIF5B's interaction with various binding partners or cargoes it transports within the cell. PMA, an activator of PKC, and Forskolin, which elevates cAMP levels and subsequently activates PKA, may both influence KIF5B by phosphorylating proteins that affect kinesin-microtubule interactions or the motor's activity itself.
In the context of Ubiquitous Kinesin Heavy Chain Activators, Lithium Chloride and CPA serve as indirect enhancers of KIF5B's motor function by influencing the stability of microtubules through GSK-3β inhibition and modulating cAMP levels, respectively. 5-Iodotubercidin raises adenosine levels, thereby affecting PKA signaling and potentially increasing KIF5B activity through similar cAMP-dependent pathways. The cAMP analog db-cAMP directly activates PKA, which could lead to enhanced phosphorylation of proteins that regulate KIF5B. Collectively, these compounds utilize diverse pathways to bolster the activity of KIF5B, ensuring efficient transport of cargoes along the cytoskeletal network, crucial for various cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ATP | 56-65-5 | sc-507511 | 5 g | $17.00 | ||
ATP is the primary energy currency of the cell and is required by Ubiquitous Kinesin Heavy Chain for its motor activity. Binding and hydrolysis of ATP by KIF5B result in conformational changes that drive the motor's movement along microtubules. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and can enhance the processivity of KIF5B by reducing the rate of microtubule depolymerization, thereby extending the tracks on which KIF5B operates. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/Akt signaling pathway, which can indirectly enhance KIF5B function by phosphorylating downstream targets that regulate kinesin-microtubule interactions. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is a phosphatase inhibitor that can lead to increased phosphorylation levels of cellular proteins, potentially affecting KIF5B function by altering its interaction with binding partners or cargo. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases PP1 and PP2A, leading to hyperphosphorylation of proteins, which may indirectly enhance KIF5B activity by modulating its cargo-binding capacity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator that can phosphorylate a wide range of targets within the cell, potentially influencing KIF5B function by altering its interaction with microtubules or motor-associated proteins. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP levels, which can activate PKA. PKA phosphorylation can modulate the activity of KIF5B by affecting its motor domain or associated cargo proteins. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride inhibits GSK-3β, which could lead to the stabilization of microtubules and indirectly enhance the activity of KIF5B by providing more stable tracks for its movement. | ||||||
5-Iodotubercidin | 24386-93-4 | sc-3531 sc-3531A | 1 mg 5 mg | $153.00 $464.00 | 20 | |
5-Iodotubercidin is an adenosine kinase inhibitor that increases the levels of adenosine, which can influence cAMP and PKA signaling, potentially leading to enhanced activity of KIF5B. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cell-permeable cAMP analog that activates PKA, which may increase KIF5B activity by phosphorylating proteins that regulate kinesin-microtubule interactions or motor activity. | ||||||